Neurodegenerative diseases and oxidative stress

Biomedicine and Pharmacotherapy

Volumn 58, Issue 1, 2004, Pages 39-46

  Emerit, J ^a   Edeas, M ^b,c   Bricaire, F ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c International Antioxidants Task Force   (France)

Author keywords

Apoptosis; Excitotoxity; Mitochondrial dysfunction

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUTAMATE RECEPTOR; NITRIC OXIDE SYNTHASE; PROTEASOME; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ASTROCYTE; BRAIN; CALCIUM MOBILIZATION; CELL ENERGY; CELL FUNCTION; CYTOTOXICITY; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FRIEDREICH ATAXIA; GENETIC ANALYSIS; HUMAN; HUNTINGTON CHOREA; INFLAMMATION; ION TRANSPORT; MICROGLIA; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NERVE CELL; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SYNTHESIS; UBIQUITINATION;

EID: 1642483509     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2003.11.004     Document Type: Review

References (65)

1. Adamson D.C., Wilddemann B., Sasaki M., et al. Immunologic NOS: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science. 274:1996;1917-1921.
2. Blalock E.M., Chen K.-C., Sharrow K., Herman J.P., Porter N.M., Fosterd T.C., et al. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci. 23:2003;3807-3819.
3. Bandy B., Davidson A.J. Mitochhondrial mutations may increase oxidative stress. Free Radical Biol Med. 8:1990;523-529.
4. Bates G. Hungingtin aggregation and toxicity in Hutington's disease. Lancet. 61:2003;1642-1644.
5. 10 attenuates the MPTP induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res. 783:1998;109-114.
6. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 38:1995;557-568.
7. Beal M.F. Does impairment of energy metabolism results in excitotoxic neuronal death in neurodegenerative illnesses. Ann Neurol. 31:1992;119-130.
8. Beal M.F. Energetics in the pathogenesis of neurodegenerative diseases. TINS. 23:2000;298-304.
9. Bukrinsky M.I., Nottet H.S., Schmidtmayerova H., Dubrovsky L., Flanagan C.R., Mullins M.E., et al. Regulation of nitric oxide synthase activity in HIV-1 infected monocytes: implications for HIV-associated neurological disease. J Exp Med. 181:1995;735-745.
10. Casarino D.S., Bennett J.P. Jr. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neuro-degeneration. Brain Res Rev. 29:1999;1-25.
11. Cortopassi G.A., Wong A. Mitochondria in organismal aging and degeneration. Biochim Biophys Acta. 1410:1999;183-193.
12. Cote H.C.F., Brumme Z.L., Craib K.J.P., Alexander C.S., Wynhoven B., et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV infected patients. N Engl J Med. 346:2002;811-820.
13. Dawson V.L., Dawson T.M., Uhl G.R., Snyder S.H. HIV1 coat protein neurotoxicity mediated by NO in primary cortical culture. Proc Natl Acad Sci USA. 90:1993;3256-3260.
14. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. N Engl J Med. 348:2003;2656-2668.
15. Drachman D.B., Frank K., Dykes-Hiberg M., Teismann P., Almer G., Przedborski S., et al. Cyclogenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol. 52:2002;771-778.
16. Flores S.C., Marecki J.C., Harper K.P., Bose S.K., Nelson S.K., McCord J.M. Tat protein of HIV 1 represses expression of MnSOD in Hela cells. Proc Natl Acad Sci USA. 90:1993;7632-7636.
17. Friedlander R.M. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med. 348:2003;1365-1375.
18. Garden G.A., Budd S.L., Tsai E., Hanson L., D'Emilia D.M., Friedlander R.M., et al. Caspase cascades in HIV-associated neurodegeneration. J Neurosci. 22:2002;4015-4024.
19. Gurney M.E., Cuttings F.B., Zai P., et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of FALS. Ann Neurol. 39:1996;147-157.
20. Halliwell B., Gutteridge J.M.C. Oxidative stress in AD. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 1999;744-758 Oxford University Press, New York.
21. Halliwell B., Gutteridge J.M.C. Antioxidant defenses. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 1999;134-231 Oxford University Press, New York.
22. Harman D. Free radical theory of aging. Mutat Res. 275:1992;257-258.
23. Hensley K., Carney J.M., Mattson M.P., et al. A model of β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc Natl Acad Sci USA. 91:1994;3270s-3274s.
24. Jackson M.J., Papa S., Bolanos J., Bruckdofer R., et al. Antioxidants, ROS and RNS, gene induction and mitochondrial function. Mol Aspects Med. 23:2002;209-285.
25. Johns D.R. Mitochondrial DNA and disease. N Engl J Med. 333:1995;638-644.
26. Kriz J., Gowing G., Julien J.-P. Efficient three-drug cocktail for disease induce by mutant SOD. Ann Neurol. 53:2003;429-436.
27. Kokoszka J.E., Coskum P., Esposito L.A., Wallace D.C. Increased mitochondrial oxidative stress in the SOD2(+/-)moue results in the age related mitochondrial function. Proc Natl Acad Sci USA. 98:2001;2278-2283.
28. Kruman I.I., Nath A., Mattson M.P. Tat induces apoptosis in hippoccampal cultured neurons, by a mechanism involving caspase activation, calcium overload and oxidative stress. Exp Neurol. I54:1998;276-296.
29. Kurosinski P., Götz J. Glial cells under physiologic and pathologic conditions. Arch Neurol. 59:2002;1524-1528.
30. Lee C.-K., Klopp R.G., Weindruch R., Prolla T.A. Gene expression profile of aging and its retardation by caloric restriction. Science. 285:1999;1390-1393.
31. Levine R.L. Oxidative modification of glutamine-synthase. J Biol Chem. 258:1983;11826-11827.
32. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 330:1994;613-622.
33. Lipton S.A., Choi Y.-B., Pan Z.H., et al. A redox based mechanism for the neuroprotective and neurodestructive effects of NO and related nitroso-compounds. Nature. 364:1993;626-632.
34. Lipton S.A., Gendelman H.E. Dementia associated with AIDS. N Engl J Med. 332:1995;934-940.
35. Liu J., Killilea D.W., Ames B.N. Age associated mitochondrial oxidative decay. Improvement of carnitine acetyl transferase substrate binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-α-lipoic acid. Proc Natl Acad Sci USA. 99:2002;1876-1881.
36. Mark R.J., Blanc E.M., Mattson M.P. Amyloid-β-peptide and oxidative cellular injury in Alzheimer's disease. Mol Neurobiol. 12:1996;211-224.
37. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol Med. 23:1997;134-147.
38. Martin J.B. Molecular basis of the neurodegenerative disorders. N Engl J Med. 340:1999;1970-1980.
39. Mattson M.P. Advances fuel AD conumdrum. Nature Genet. 17:1997;254-256.
40. Mattson M.P., Lovell M.A., Furukawa K., Markesbery W.R. Neurotrophic factors attenuate glutamate induced accumulation of peroxides elevation of intracellular calcium concentration, and neurotoxicity and increase antioxidant enzyme activities in hippoccampal neurons. J Neurochem. 65:1995;1740-1751.
41. Mattson M.P. Neuroprotective signaling and the aging brain: take away my food and let me run. Brain Res. 886:2000;47-53.
42. Mecocci P., MacGarvey U., Kaufman A.E., et al. Oxidative damage to mitochondrial DNA shows marked age dependent increases in human brain. Ann Neurol. 34:1993;609-616.
43. Merlini G., Belloti V. Molecular mechanisms of amyloidosis. N Engl J Med. 349:2003;583-596.
44. Musumeci O., Naini A., Slonim A.E., Skavin P.T., Hadjigeorgiou G.L., et al. Familial cerebellar ataxia with muscle coenzyme Q deficiency. Neurology. 56:2001;849-855.
45. Nussbaum R.L., Ellis C.E. Alzheimer's disease and Parkinson disease. N Engl J Med. 348:2003;1356-1364.
46. Olsen M.K., Oberds S.L., Ellerbrock B.R., Fleck T.J., McKinley D.K., Gurney M.E. Disease mechanism revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol. 50:2001;730-740.
47. Pompl P.N., Yemul S., Xiang Z., Ho L., Harroutian V., Purohit D., et al. Caspase gene expression in the brain as a function of the clinical progression of AD. Arch Neurol. 60:2003;369-376.
48. Rosenberg R.N. Mitochondrial therapy for PD. Arch Neurol. 59:2002;1523.
49. Rosenberg R.N. The molecular and genetic basis of AD: the end of beginning. Neurology. 54:2000;2045-2054.
50. Rowland L.P., Schneider N.A. Amyotrophic lateral sclerosis. N Engl J Med. 344:2001;1688-1700.
51. Sano M., Ernesto C., Thmas R.G., et al. A controlled trial of Selegine alpha-tocopherol or both as treatment for Alzheimer's disease. N Engl J Med. 336:1997;1216-1222.
52. Sassaki M., Gonzlalez-Zulueta M., Huang H., Herring W.J., Ahn S., Ginty D.D., et al. Dynamic regulation of nNOS transcription by calcium influx trough a CREB family transcription factor dependent mechanism. Proc Natl Acad Sci USA. 97:2000;8617-8622.
53. Scandalios J.G. Oxidative stress response - what genome scale-studies taught us? Genome Biol. 3:(1019):2002;1-6.
54. Shibata N., Hirano A., Kobayashi A., et al. Cu-Zn SOD like immuno reactivity in Lewy body-like inclusions of sporadic ALS. Neurosci Lett. 179:1994;149-152.
55. Shigenaga M.K., et al. Oxidative damage and mitochondrial decay in ageing. Proc Natl Acad Sci USA. 91:1994;10771.
56. Shults C.W., Oakes D., Kieburtz K., Beal M.F. Effects of coenzyme Q10 in early PD. Arch Neurol. 59:2002;1541-1550.
57. Sohal R.S., Weindruch R. Oxidative stress, caloric restriction and aging. Science. 273:1996;58-63.
58. Tanzi R.E., Bertram L. News frontiers in Alzheimer's genetics. Neuron. 32:2001;181-184.
59. Van Maldergem L., Trijbels F., Di mauro S., Sindelar P.J., Musumeci O., et al. Coenzyme Q responsive Leigh's encephalopathy in two sisters. Ann Neurol. 52:2002;754.
60. Wallace D.C. Diseases of the mitochondrial DNA. Annu Rev Biochem. 61:1992;1175-1212.
61. Weindruch R., Prolla T.A. Gene expression profile of the aging brain. Arch Neur. 59:2002;1712-1714.
62. Wüllner U., Seyfried J., Groscurth P., et al. Glutathione depletion and neuronal cell death: the role of ROS and mitochondrial function. Brain Res. 826:1999;53-62.
63. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J., Takeuchi H., et al. Differential expression of inflammation and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial ALS. J Neurochem. 80:2002;158-167.
64. Yun H.Y., Dawson V.L., Dawson T.M. Neurobiology of nitric oxide. Crit Rev Neurobiol. 10:1996;291-316.
65. Zhang K., Ranaa F., Silva C., Ethier J., Werhly K., Chesebro B., et al. HIV1 envelope-mediated neuronal death: uncoupling of viral replication and neurotoxicity. J Virol. 7:2003;6899-6912.